Risk of prostate cancer in patients with schizophrenia

Gil Raviv, Menachem Laufer, Yehuda Baruch, Yoram Barak*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Objectives To examine the rate of prostate cancer in a cohort of schizophrenia in-patients in the PSA-era as compared to expected rates. There is conflicting evidence on the relative risk of prostate cancer in men with schizophrenia.

Methods the study sample was comprised of schizophrenia patients who had been admitted to a tertiary care mental health center between 1990 and 2011. The data for the sample was cross-referenced with the National Cancer Registry. Analyses of Standardized Incidence Rates (SIR) for prostate cancer and for lung cancer (representing an organ system not sensitive to sex hormones) were performed.

Results Of 4,326 schizophrenia patients included in the present study, 181 (4.2%) were diagnosed with cancer at any site. Only 10 of these patients were diagnosed with prostate cancer. This reflects a reduced risk; SIR of 0.56 (95% CI 0.27-1.03). In the same cohort, 33 schizophrenia patients were diagnosed with lung cancer presenting a SIR of 1.43 (95% CI 0.98-2.01) in this sample.

Conclusions The present study suggests a reduced rate of prostate cancer in patients admitted for schizophrenia. There are several possible explanations for this finding including chronic state of hyperprolactinemia induced by antipsychotic drugs.

Original languageEnglish
Pages (from-to)1639-1642
Number of pages4
JournalComprehensive Psychiatry
Issue number7
StatePublished - 1 Oct 2014


Dive into the research topics of 'Risk of prostate cancer in patients with schizophrenia'. Together they form a unique fingerprint.

Cite this